Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hand-Foot Skin Reaction (HFSR) 1Depression 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Psilocybin 5Psychotherapy 2Fluoxetine 2Cannabidiol 2nabiximols 1Yoga 1Therapeutics 1Sertraline 1Self-Management 1Selective Serotonin Reuptake Inhibitors 1Professional Autonomy 1Pharmaceutical Preparations 1Niacin 1Neoadjuvant Therapy 1N-Methyl-3,4-methylenedioxyamphetamine 1Minocycline 1Medical Marijuana 1Ketamine 1Injections 1Hormones 1Gemcitabine 1Exercise 1Dronabinol 1Donepezil 1Clomipramine 1Citalopram 1Cisplatin 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anxiety Disorders × Niacin × Clear all
NCT06200155 2026-04-16

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled

Anxiety Disorders, Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡